205 related articles for article (PubMed ID: 38609948)
1. Targeting of REST with rationally-designed small molecule compounds exhibits synergetic therapeutic potential in human glioblastoma cells.
Panina SB; Schweer JV; Zhang Q; Raina G; Hardtke HA; Kim S; Yang W; Siegel D; Zhang YJ
BMC Biol; 2024 Apr; 22(1):83. PubMed ID: 38609948
[TBL] [Abstract][Full Text] [Related]
2. Targeted Covalent Inhibition of Small CTD Phosphatase 1 to Promote the Degradation of the REST Transcription Factor in Human Cells.
Medellin B; Yang W; Konduri S; Dong J; Irani S; Wu H; Matthews WL; Zhang ZY; Siegel D; Zhang Y
J Med Chem; 2022 Jan; 65(1):507-519. PubMed ID: 34931516
[TBL] [Abstract][Full Text] [Related]
3. Phosphatase activity of small C-terminal domain phosphatase 1 (SCP1) controls the stability of the key neuronal regulator RE1-silencing transcription factor (REST).
Burkholder NT; Mayfield JE; Yu X; Irani S; Arce DK; Jiang F; Matthews WL; Xue Y; Zhang YJ
J Biol Chem; 2018 Oct; 293(43):16851-16861. PubMed ID: 30217818
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of REST Suppresses Proliferation and Migration in Glioblastoma Cells.
Zhang D; Li Y; Wang R; Li Y; Shi P; Kan Z; Pang X
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153061
[TBL] [Abstract][Full Text] [Related]
5. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
[TBL] [Abstract][Full Text] [Related]
6. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Marisetty AL; Lu L; Veo BL; Liu B; Coarfa C; Kamal MM; Kassem DH; Irshad K; Lu Y; Gumin J; Henry V; Paulucci-Holthauzen A; Rao G; Baladandayuthapani V; Lang FF; Fuller GN; Majumder S
Neuro Oncol; 2019 Jun; 21(6):775-785. PubMed ID: 30953587
[TBL] [Abstract][Full Text] [Related]
7. PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells.
Wang R; Degirmenci V; Xin H; Li Y; Wang L; Chen J; Hu X; Zhang D
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065155
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
9. An expression based REST signature predicts patient survival and therapeutic response for glioblastoma multiforme.
Liang J; Meng Q; Zhao W; Tong P; Li P; Zhao Y; Zhao X; Li H
Sci Rep; 2016 Oct; 6():34556. PubMed ID: 27698411
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor microRNA, miR-124a, is regulated by epigenetic silencing and by the transcriptional factor, REST in glioblastoma.
Tivnan A; Zhao J; Johns TG; Day BW; Stringer BW; Boyd AW; Tiwari S; Giles KM; Teo C; McDonald KL
Tumour Biol; 2014 Feb; 35(2):1459-65. PubMed ID: 24068568
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract][Full Text] [Related]
12. REST regulates oncogenic properties of glioblastoma stem cells.
Kamal MM; Sathyan P; Singh SK; Zinn PO; Marisetty AL; Liang S; Gumin J; El-Mesallamy HO; Suki D; Colman H; Fuller GN; Lang FF; Majumder S
Stem Cells; 2012 Mar; 30(3):405-14. PubMed ID: 22228704
[TBL] [Abstract][Full Text] [Related]
13. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
[TBL] [Abstract][Full Text] [Related]
14. DBX2 Promotes Glioblastoma Cell Proliferation by Regulating REST Expression.
He R; Zhang X; Ding L
Curr Pharm Biotechnol; 2022; 23(8):1101-1108. PubMed ID: 34463226
[TBL] [Abstract][Full Text] [Related]
15. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma.
Yu H; Zhang D; Li Z; Wang M
Pathol Res Pract; 2020 Aug; 216(8):153030. PubMed ID: 32703494
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 antagonism sensitizes cancer cells to novel indole-based MDM2/4 inhibitors in glioblastoma multiforme.
Daniele S; La Pietra V; Piccarducci R; Pietrobono D; Cavallini C; D'Amore VM; Cerofolini L; Giuntini S; Russomanno P; Puxeddu M; Nalli M; Pedrini M; Fragai M; Luchinat C; Novellino E; Taliani S; La Regina G; Silvestri R; Martini C; Marinelli L
Eur J Pharmacol; 2021 Apr; 897():173936. PubMed ID: 33581134
[TBL] [Abstract][Full Text] [Related]
17. Novel Targeting of Transcription and Metabolism in Glioblastoma.
Su YT; Chen R; Wang H; Song H; Zhang Q; Chen LY; Lappin H; Vasconcelos G; Lita A; Maric D; Li A; Celiku O; Zhang W; Meetze K; Estok T; Larion M; Abu-Asab M; Zhuang Z; Yang C; Gilbert MR; Wu J
Clin Cancer Res; 2018 Mar; 24(5):1124-1137. PubMed ID: 29254993
[No Abstract] [Full Text] [Related]
18. Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.
Cui X; Zhao J; Li G; Yang C; Yang S; Zhan Q; Zhou J; Wang Y; Xiao M; Hong B; Yi K; Tong F; Tan Y; Wang H; Wang Q; Jiang T; Fang C; Kang C
Cancer Commun (Lond); 2023 Dec; 43(12):1326-1353. PubMed ID: 37920878
[TBL] [Abstract][Full Text] [Related]
19. Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness.
Bandey I; Chiou SH; Huang AP; Tsai JC; Tu PH
Oncogene; 2015 Apr; 34(14):1853-64. PubMed ID: 24793792
[TBL] [Abstract][Full Text] [Related]
20. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH
Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
